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Abstract
Polydendrocytes (also known as NG2 glial cells) constitute a fourth major glial cell type in the adult mammalian central
nervous system (CNS) that is distinct from other cell types. Although much evidence suggests that these cells are
multipotent in vitro, their differentiation potential in vivo under physiological or pathophysiological conditions is still
controversial. To follow the fate of polydendrocytes after CNS pathology, permanent middle cerebral artery occlusion
(MCAo), a commonly used model of focal cerebral ischemia, was carried out on adult NG2creBAC:ZEG double transgenic
mice, in which enhanced green fluorescent protein (EGFP) is expressed in polydendrocytes and their progeny. The
phenotype of the EGFP
+ cells was analyzed using immunohistochemistry and the patch-clamp technique 3, 7 and 14 days
after MCAo. In sham-operated mice (control), EGFP
+ cells in the cortex expressed protein markers and displayed
electrophysiological properties of polydendrocytes and oligodendrocytes. We did not detect any co-labeling of EGFP with
neuronal, microglial or astroglial markers in this region, thus proving polydendrocyte unipotent differentiation potential
under physiological conditions. Three days after MCAo the number of EGFP
+ cells in the gliotic tissue dramatically increased
when compared to control animals, and these cells displayed properties of proliferating cells. However, in later phases after
MCAo a large subpopulation of EGFP
+ cells expressed protein markers and electrophysiological properties of astrocytes that
contribute to the formation of glial scar. Importantly, some EGFP
+ cells displayed membrane properties typical for neural
precursor cells, and moreover these cells expressed doublecortin (DCX) – a marker of newly-derived neuronal cells. Taken
together, our data indicate that polydendrocytes in the dorsal cortex display multipotent differentiation potential after focal
ischemia.
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Introduction
In general, the adult central nervous system (CNS) possesses a
limited capacity for regeneration after injury, including ischemia.
Following ischemic injury, neural tissue recovery is accompanied
by the formation of reactive astrogliosis; this process is vital for
isolating necrotic tissue from its uninjured surroundings, but
concurrently, it markedly impedes regenerative processes. Shortly
after ischemia, a series of ionic, neurotransmitter and oxidative
radical imbalances occurs that lead to the activation of microglia
and subsequently to an increased number of reactive astrocytes.
Both cell types release cytokines and other soluble products [1]
that play an important role in consecutive processes, including the
apoptosis of oligodendrocytes [2] and neurons [3]. Besides the
main, well characterized cell types, other cells including poly-
dendrocytes, endothelial cells and pericytes exist in neural tissue;
however, our knowledge regarding their functional roles during
and after brain ischemia remains limited.
Recently, attention has turned to polydendrocytes and their
possible role in regeneration following CNS injuries. Polyden-
drocytes in the adult brain, known as NG2 glia or oligodendrocyte
precursor cells, can be identified by their highly branched
morphology and their expression of NG2 proteoglycan (NG2)
together with platelet-derived growth factor alpha receptor
(PDGFaR) [4]. These cells represent a fourth glial population in
the mammalian brain, distinct from mature oligodendrocytes,
astrocytes or microglia. Until recently they have been assumed to
give rise only to oligodendrocytes in the intact adult CNS,
although polydendrocytes are known to be capable of generating
neurons and astrocytes in vitro in the presence of specific
morphogens [5,6] and in vivo after transplantation into the
hippocampus [7].
Using lineage-specific Cre transgenes, genetic fate-mapping
studies in the intact CNS have revealed inconsistent findings. The
capability of polydendrocytes to differentiate into oligodendrocytes
in vivo was clearly confirmed by [8]; however, [9] also described the
differentiation of polydendrocytes into grey matter astrocytes.
Moreover, several recent studies have described the generation of
new neurons in the piriform cortex from polydendrocytes in
PDGFaR- or Plp-promoter-driven Cre transgenic mice [8,10]. On
the other hand, in NG2- or Olig2- promoter-driven Cre transgenic
animals, such neuronal differentiation was not observed [9,11].
In CNS pathologies such as global cerebral ischemia, poly-
dendrocytes upregulate NG2 and significantly increase their
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36816proliferation rate [12,13]. Apparently, the pathophysiological
changes at the site of injury may enable polydendrocytes to
display larger lineage plasticity and thus contribute to CNS
regeneration; nevertheless, the electrophysiological properties of
polydendrocytes and their fate after CNS injury have not been
determined in detail.
In the present study, we examined the fate of polydendrocytes in
vivo after focal ischemia using transgenic mice that express Cre
under the control of the NG2 promoter. We performed complex
immunohistochemical and electrophysiological analyses to deter-
mine the differentiation potential of polydendrocytes and the
electrophysiological properties of the newly-derived cells after
ischemia in adult mice.
Materials and Methods
Transgenic mice
All procedures involving the use of laboratory animals were
performed in accordance with the European Communities
Council Directive 24 November 1986 (86/609/EEC) and animal
care guidelines approved by the Institute of Experimental
Medicine ASCR Animal Care Committee. The generation of
NG2creBAC transgenic mice, which express constitutively active
Cre in NG2 cells, has been described previously [9]. NG2creBAC
mice were crossed with the reporter mouse strain Z/EG to
generate NG2creBAC:ZEG double transgenic mice. The mice
carrying both modifications were selected by PCR. These double
transgenic mice express Cre recombinase under the control of the
mouse NG2 (Cspg4) promoter/enhancer. In the Cre recombinase-
expressing cells, lacZ expression is replaced with EGFP expression,
and these cells can be easily visualized and tracked. Since we
detected no sex differences, both male and female mice were used
in our experiments. All mouse strains were obtained from The
Jackson Laboratory, Bar Harbor, USA.
Induction of distal middle cerebral artery occlusion
(MCAo) in adult mice
Mice (60–90 days old) were anaesthetized for induction with
1.5% Isoflurane and maintained in 1% Isoflurane using a
vaporizer (Tec-3, Cyprane Ltd., Keighley, UK). A skin incision
between the orbit and the external auditory meatus was made. A
1–2 mm hole was drilled through the frontal bone 1 mm rostral to
the fusion of the zygoma and the squamosal bone and about
3.5 mm ventral to the dorsal surface of the brain. The middle
cerebral artery (MCA) was exposed after the dura was opened and
removed. The MCA was occluded by short coagulation with
bipolar tweezers at a proximal location, followed by transection of
the vessel to ensure permanent disruption. The mice received
0.5 ml saline subcutaneously, and the body temperature during
the surgery was maintained at 3761uC using a heating pad. Sham
operated animals (controls) were subjected to same surgery
procedure, without vessel occlusion. To visualize the ischemic
region, unfixed brain slices were stained with 2% 2.3.5-
triphenyltetrazolium chloride (TTC) at 37uC for 20 minutes.
Preparation of acute brain slices
The mice were deeply anaesthetized 3, 7 or 14 days after MCAo
(3, 7, 14d MCAo) with pentobarbital (PTB) (100 mg/kg, i.p.) and
perfused transcardially with cold (4–8uC) isolation solution
containing (in mM): 110 NMDG-Cl, 2.5 KCl, 24.5 NaHCO3,
1.25 Na2HPO4, 0.5 CaCl2, 7 MgCl2, 20 glucose, osmolality
290 mOsm/kg. The mice were decapitated, the brains were
quickly dissected out and transversal 200 mm thick slices were cut
using a vibration microtome (HM 650 V, Thermo Scientific
Microm, Walldorf, Germany). The slices were incubated for
30 minutes at 34uC in the isolation solution and then held at room
temperature in artificial cerebrospinal fluid solution (aCSF)
containing (in mM): 122 NaCl, 3 KCl, 28 NaHCO3, 1.25
Na2HPO4, 1.5 CaCl2, 1.3 MgCl2, 10 glucose, osmolality
305 mOsm/kg. Solutions were equilibrated with 95% O2/5%
CO2 to a final pH of 7.4. Osmolality was measured using a vapor
pressure osmometer (Vapro 5520, Wescor, Logan, UT, USA).
Electrophysiological recordings
Acute brain slices were transferred to a recording chamber
mounted on the stage of an upright microscope (Axioscop, Zeiss,
Gottingen, Germany) equipped with a high-resolution digital
camera (AxioCam HRc, Zeiss, Germany) and electronic micro-
manipulators (Luigs & Neumann, Ratingen, Germany). The
chamber was continuously perfused with oxygenated aCSF at a
rate of 3 ml/min at 2562uC. Electrophysiological recordings were
performed using an EPC-10 patch-clamp amplifier in combination
with PATCHMASTER software (HEKA Elektronik, Lambrecht/
Pfalz, Germany). Recording pipettes with a tip resistance of
,10 MV were made from borosilicate capillaries (0.86 ID, Sutter
Instruments Company, Novato, CA, USA) using a Brown-Flaming
micropipette puller (P-97, Sutter Instruments). Electrodes were
filled with an intracellular solution containing (in mM): 130 K-
gluconate, 0.5 CaCl2, 5 EGTA, 10 HEPES, 3 Mg-ATP and 0.3
Na-GTP; the final pH was adjusted to 7.2 with KOH. The resting
membrane potential (RMP) was measured by switching the EPC-
10 amplifier to the current-clamp mode. The membrane resistance
(Rm) was calculated from the current elicited by a 10 mV test
pulse depolarizing the cell membrane from the holding potential of
270 mV to 260 mV for 50 ms, 40 ms after the onset of the
depolarizing pulse. Membrane capacitance (Cm) was determined
automatically from the Lock-in protocol by PATCHMASTER.
Clamping the cell membrane from the holding potential of
270 mV to values ranging from 2160 mV to +40 mV for 50 ms
at 10 mV intervals evoked membrane currents. To isolate the
voltage-gated delayed outwardly rectifying K
+ (KDR) current
component, a voltage step from 270 to 260 mV was used to
subtract time- and voltage-independent currents. To activate the
KDR currents only, the cells were held at 250 mV, and the
amplitude of the KDR currents was measured at +40 mV at the
end of the pulse. The fast activating and inactivating outwardly-
rectifying K
+ (KA) current component was isolated by subtracting
the current traces clamped at 2110 mV from those clamped at
250 mV, and its amplitude was measured at the peak value.
Tetrodotoxin- (TTX, Alomone Labs, Jerusalem, Israel) sensitive
Na
+ currents were isolated by subtracting the current traces
measured in 1 mM TTX-containing solution from those measured
under control conditions. Na
+ currents amplitudes were measured
at the peak value. Inwardly-rectifying K
+ (KIR) currents were
determined at 2160 mV at the end of the pulse. Current densities
(CD) were calculated by dividing the maximum current ampli-
tudes by the corresponding Cm for each individual cell. The
patch-clamp data analyses were performed using FITMASTER
software (HEKA Elektronik, Lambrecht/Pfalz, Germany).
Immunohistochemistry and cell identification
The mice were deeply anaesthetized 3, 7, or 14 days after
MCAo with PTB (100 mg/kg, i.p.) and perfused transcardially
with 20 ml of saline followed by 20 ml of cooled 4% paraformal-
dehyde (PFA) in 0.1 M phosphate buffer (PB). Brains were
dissected out, post-fixed for 2 hours and placed stepwise in
solutions with gradually increasing sucrose concentrations (10%,
20%, 30%) for cryoprotection. Coronal, 30 mm thick slices were
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Walldorf, Germany). For cell identification after patch-clamp
recording, the measured cells were filled with Alexa Fluor 594
hydrazide (0.1 mM; Molecular Probes, Invitrogen, CA, USA) by
dialyzing the cytoplasm with the patch pipette solution. Post-
recording, the slices were fixed with 4% PFA in 0.1 M PB for
25 minutes and then kept at 4–8uC in phosphate-buffered saline
(PBS). The slices were incubated with 5% Chemiblocker
(Millipore, MA, USA) and 0.2% Triton in PBS. This blocking
solution was also used as the diluent for the antisera. The slices
were incubated with the primary antibodies at 4–8uC overnight,
and the secondary antibodies were applied for 2 hours. The list of
primary and secondary antibodies is summarized in Table 1. To
visualize the cell nuclei, the slices were incubated with 300 nM 4,
6-diamidino-2-phenylindole (DAPI) in PBS for 5 minutes at room
temperature and mounted using Aqua Poly/Mount (Polysciences
Inc., Eppelheim, Germany). All chemicals were purchased from
Sigma–Aldrich (St. Louis, MO, USA), unless otherwise stated.
A Zeiss 510DUO LSM confocal microscope equipped with
Arg/HeNe lasers and 406 or 636 oil objectives was used for
immunohistochemical analysis. Stacks of consecutive confocal
images taken at intervals of 3 mm were acquired sequentially with
two lasers to avoid cross-talk between fluorescent labels. The
background noise of each confocal image was reduced by
averaging four image inputs. For each image stack the gain and
detector offset were adjusted to minimize saturated pixels, yet still
permit the detection of weakly stained cell processes. Colocaliza-
tion images and their maximum z projections were made using a
Zeiss LSM Image Browser.
Cell counts
To determine the fate of polydendrocytes in the peri-lesional
cortex, confocal images (315 mm6315 mm620 mm) covering the
borders of the ischemic core were taken from brain coronal slices
from control mice and from mice 3, 7 and 14 days after MCAo (5–
7 animals from each group, 5 regions from one slice, bregma
21.2 mm) and stained for NG2, nestin, glial fibrillary acidic
protein (GFAP), Ki-67 and doublecortin (DCX). The total number
of EGFP positive (EGFP
+) cells and the number of cells that were
double positive for EGFP and NG2, nestin, Ki-67, GFAP or DCX
were counted in the cortex within the astrogliotic region. Between
1000 and 1500 EGFP
+ cells were scored. The number of cells was
estimated from superimposed images using a GSA Image Analyzer
v3.7.7 (Bansemer & Scheel GbR, Rostock, Germany) and
expressed as the percentage of double-positive cells from the total
number of EGFP
+ cells.
Statistics
The results are expressed as the mean 6 SEM. Statistical
analyses of the differences between groups were performed using
one-way ANOVA for multiple comparisons with Dunnett’s post-
hoc test. Values of p,0.05 were considered significant (*), p,0.01
very significant (**) and p,0.001 extremely significant (***).
Results
Under physiological conditions EGFP expression is
restricted to polydendrocytes and oligodendrocytes in
the dorsal cortex of NG2creBAC:ZEG mice
To determine the fate of polydendrocytes in vivo, we used a
transgenic mouse strain in which Cre recombinase is expressed
under the control of the mouse NG2 promoter [9]. After crossing
with Z/EG reporter mice, the NG2creBAC:ZEG mice exhibited
widespread EGFP expression in a large population of cells in the
brain and spinal cord. Polydendrocytes express NG2 and
PDGFaR [14]; however, both proteins are downregulated
immediately upon differentiation. Therefore, our approach
enabled us to follow the fate of differentiating polydendrocytes
based on their EGFP labeling.
To determine the phenotype of EGFP
+ cells in the adult brain,
we performed a complex immunohistochemical analysis of brain
coronal sections; first, we counted the total number of EGFP
+ cells
in the dorsal part of the cortex of the control animals. We found
98926783 EGFP
+ cells per mm
3, which represented 4.1%60.3%
of all DAPI
+ cells. EGFP
+ cells could be divided into several
morphological types. The first, most common morphological
phenotype comprised cells with several highly branched processes
and small round cell bodies, characteristics typical of polyden-
drocytes. These cells were predominantly positive for the
polydendrocytic markers NG2 and PDGFaR (Fig. 1A, B). NG2
proteoglycan was uniformly expressed on the surface of the cell
body and processes; however, staining for PDGFaR revealed its
typical polarized expression [8]. EGFP was expressed in
89%62.3% of NG2
+ cells throughout the brain, while
55.4%61.2% of EGFP
+ cells expressed NG2 in the cortex of
control mice, which is in agreement with previous studies
performed on this mouse strain [9,15]. The lack of EGFP
detection in approximately 11% of NG2
+ cells may have been
caused by the lack of Cre expression or incomplete Cre-mediated
Table 1. Primary and secondary antibodies used for
immunohistochemistry.
Antigen Dilution Isotype Manufacturer
Secondary
antibody
Aldh1 1:100 Mouse IgG NeuroMab GAM 594/660
APC 1:200 Mouse IgG Calbiochem GAM 594/660
Caspase-3 1:300 Mouse IgG Alexis Biochem. GAM 660
CD11b 1:200 Mouse IgG Millipore GAM 594
DCX 1:1000 Rabbit IgG Abcam GAR 594/660
GFAP 1:800 Mouse IgG Sigma-Aldrich Cy3 conjugated
GFP 1:800 Goat IgG Abcam FITC conjugated
GLAST 1:500 Rabbit IgG Abcam GAR 594/660
Ki-67 1:1000 Rabbit IgG Abcam GAR 594/660
Nestin 1:800 Mouse IgG Millipore GAM 594/660
Neun 1:100 Mouse IgG Millipore GAM 594
NG2 1:400 Rabbit IgG Millipore GAR 594/660
Olig-2 1:1000 Rabbit IgG Millipore GAR 660
Pax-6 1:300 Rabbit IgG Covance GAR 594
PCNA 1:500 Mouse IgG Abcam GAM 594
PDGFaR 1:200 Rabbit IgG Santa Cruz GAR 594/660
PDGFbR 1:200 Rabbit IgG Santa Cruz GAR 594/660
S100b 1:150 Mouse IgG Sigma-Aldrich GAM 660
Vimentin 1:1000 Mouse IgG Abcam GAM 594
Aldh1, aldehyde dehydrogenase–1; APC adenomatous polyposis coli; CD11b,
integrin alpha M; DCX, doublecortin; GFAP, glial fibrillary acidic protein; GFP,
green fluorescent protein; GLAST, glutamate/aspartate transporter; NG2,
chondroitin sulfate proteoglycan; PCNA, proliferating cell nuclear antigen;
PDGFaR, platelet-derived growth factor receptor alpha; PDGFbR, platelet-
derived growth factor receptor beta; S100b, b-subunit of S100 calcium binding
protein; GAR 594/660, goat anti-rabbit IgG conjugated with Alexa Fluor 594 or
660; GAM 594/660, goat anti-mouse IgG conjugated with Alexa Fluor 594 or 660
(all secondary antibodies from Invitrogen).
doi:10.1371/journal.pone.0036816.t001
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+ cells, or by the inadequate expression of
the reporter driven by the promoter in Z/EG mice. NG2
+ cells are
known to possess the highest proliferation rate in the adult
mammalian brain, which was confirmed by immunostaining for
Ki-67 (a nuclear cellular marker of proliferation). In the dorsal
cortex, 3.7%61.3% of EGFP
+ cells expressed Ki-67 and
20.6%62.3% of EGFP
+ cells expressed PCNA, which is in
agreement with previously published data [13,16]. This discrep-
ancy between the numbers of Ki-67- and PCNA-positive EGFP
+
cells is probably caused by the longer-lasting stability of PCNA
when compared to Ki-67 [17].
The second group of EGFP
+ cells displayed a typical
oligodendrocyte morphology, with large, round cell bodies; they
expressed the oligodendrocytic marker Adenomatous polyposis
coli (APC, Fig. 1C) and represented 27.663.5% of the total
number of EGFP
+ cells. The third group of EGFP
+ cells in the
dorsal cortex had a morphology resembling that of pericytes and,
accordingly, they expressed the marker of pericytes – platelet-
derived growth factor beta receptor (PDGFbR) – on their
cytoplasmatic membrane (Fig. S1A).
Since it has been shown that in some Cre transgenics a certain
subpopulation of astrocytes can be EGFP
+ [11,18], we analyzed
the dorsal cortex for the expression of several astrocytic markers.
Nonetheless, we did not detect EGFP
+ cells expressing any
astrocytic markers, such as GFAP, glutamate/aspartate transport-
er (GLAST) or aldehyde dehydrogenase-1 (Aldh1). However, a
subpopulation of EGFP
+ cells expressed the b-subunit of S100
calcium binding protein (S100b, Fig. 1D). Since S100b is not a
specific astrocytic marker and is expressed in astrocytes as well in
polydendrocytes [10,19], we cannot describe these cells as
astrocytes. Moreover, these EGFP
+/S100b
+ cells expressed NG2
and had the typical morphology of polydendrocytes (Fig. 1D), thus
classifying them as polydendrocytes. Finally, we also tested
whether some EGFP
+ cells expressed markers of microglia, but
we never detected any EGFP
+ cells positive for integrin alpha M
(CD11b) or Iba-1 (Fig. S1B) – commonly used markers of
microglia. Based on our extensive immunohistochemical analysis
of the uninjured adult dorsal cortex, we can conclude that the
expression of EGFP is restricted only to polydendrocytes,
oligodendrocytes and pericytes in adult NG2creBAC:ZEG double
transgenic mice.
Increased proliferation of polydendrocytes in response to
focal cerebral ischemia
To determine whether polydendrocytes in the dorsal cortex of
adult mice display an extended differentiation potential in
response to ischemic injury, we took advantage of NG2creBAC:-
ZEG double transgenic mice to enable us to follow cells with NG2
Figure 1. Enhanced green fluorescent protein (EGFP) expression is restricted to polydendrocytes and oligodendrocytes in the
control dorsal cortex of NG2creBAC:ZEG mice. A, Immunostaining for NG2 proteoglycan in the cortex illustrating the high number of EGFP
+/
NG2
+ cells. White arrows highlight several examples. B, The same population of EGFP
+ cells expressed platelet-derived growth factor alpha (PDGFaR)
in a typical polarized pattern only in part of the processes. C, A subpopulation of EGFP
+ cells in the dorsal cortex expressed the oligodendrocyte
lineage marker adenomatous polyposis coli (APC). D, Double immunohistochemistry revealed the co-expression of b-subunit of S100 calcium binding
protein (S100b) with NG2 in EGFP
+ cells, which excludes S100b as a specific marker of astrocytes. The EGFP
2/NG2
2 cells are astrocytes (indicated by
arrowheads). Scale bars, 50 mm.
doi:10.1371/journal.pone.0036816.g001
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recently used in a study that described the differentiation of
polydendrocytes after a stab wound injury [15] and simultaneous-
ly, this study confirmed the suitability of this mouse strain for use
in these types of experiments. In contrast to this study we used a
highly reproducible model of mouse MCAo with a minimal
mortality rate and high reproducibility [20]. Three days after
MCAo the ischemic lesion developed in the dorsal brain and
occupied approximately one-third of the cortex in the left
hemisphere (Fig. 2A). The necrotic tissue was surrounded by
massive astrogliosis beginning 3 days after MCAo with a maximal
intensity of GFAP staining 7 days after MCAo (Fig. 2B). The size
of the ischemic lesion and the intensity of GFAP staining gradually
decreased starting on the seventh day of ischemia, and 14 days
after MCAo the lesion comprised approximately 25% of its
original size.
Three days after MCAo the number, distribution and
morphology of EGFP
+ cells were significantly changed at the
lesion border (Fig. 3D–F) when compared to controls (Fig. 3A–C).
EGFP
+ cells had larger cell bodies with a smaller number of
processes, and their numbers significantly increased (2479861937
EGFP
+ cells/mm
3;p ,0.001). The estimated number represented
9.8%60.6% of all DAPI
+ cells and was approximately 2.5-fold
higher than that found in controls (Fig. 4A2, C). At this time point
only 36.0%62.9% of EGFP
+ cells expressed NG2 (Fig. 3D, 4D),
while in 19.6%61.5% of EGFP
+ cells we detected the expression
of nestin, which is an intermediate filament upregulated in
immature proliferating glia [21] (Fig. 3E). The number of EGFP
+/
nestin
+ cells was significantly increased when compared to controls
(Fig. 4D; p,0.001). Furthermore, the number of proliferating
cells, which were positive for Ki-67, significantly increased 3 days
after MCAo (Fig. 3F), reaching 11.5%62.7% of all EGFP
+ cells
(Fig. 4D; p,0.05) and PCNA was expressed in 59.8%62.5% of
EGFP
+ cells (Fig. S2A). Since recent studies [22] have described
the very rapid proliferation of polydendrocytes after injury, we also
examined the number of proliferating EGFP
+ cells in the very
early stage after MCAo. Two days after MCAo, 34.9% of EGFP
+
cells expressed Ki-67 and 75.5% of EGFP
+ cells expressed PCNA.
Only in a few EGFP
+ cells (6 from 990 EGFP
+ cells) did we detect
a very low expression of GFAP in the cell processes 3 days after
MCAo.
Collectively, 3 days after MCAo a large number of polyden-
drocytes expressed proliferative markers, which accords well with
the higher number of EGFP
+ cells at the lesion borders. In
addition, a large number of EGFP
+ cells appeared that did not
express polydendrocytic markers, which might already indicate
changes in their phenotype in response to ischemia.
Polydendrocytes differentiate into reactive astrocytes
and neuronal precursor cells in the later stages after
ischemia
To follow the fate of polydendrocytes and their progeny during
the later stages of astrogliosis, we analyzed brains 7 days after
MCAo. At this time point the number of EGFP
+ cells significantly
increased when compared to controls. These EGFP
+ cells had a
more complex morphology with multiple processes, and there was
a sharp interface between the ischemic/necrotic and astrogliotic
tissue. We counted 3055561355 EGFP
+ cells/mm
3, which
represented 12.5%60.4% of all DAPI
+ cells (p,0.001). This
number was 3-fold higher than in controls (Fig. 4A3, C). However,
only 25.4%61.2% of these EGFP
+ cells expressed NG2 (Fig. 3G,
4D). Moreover, a large number of newly derived cells started to
express proteins that are typical for cell types other than
polydendrocytes or oligodendrocytes. Almost 17%
(16.8%61.6%) of EGFP
+ cells expressed high levels of GFAP in
their processes (Fig. 3H, 4D, S2B), and these GFAP
+/EGFP
+ cells
were localized in regions very close to the ischemic tissue or had
even migrated directly into the ischemic core (Fig. 3H). These cells
lacked the typical bushy protoplasmic morphology but resembled
the morphology of reactive astrocytes, and some of them were
positive for markers of reactive astrocytes, such as vimentin (data
not shown). The expression of nestin in EGFP
+ cells declined 7
days after MCAo: nestin
+/EGFP
+ cells comprised 4.3%61.0% of
all EGFP
+ cells (Fig. 4D). However, nestin expression did not
entirely correlate with GFAP staining in EGFP
+ cells and was still
present in EGFP
+/NG2
+ cells. Furthermore, a small subpopula-
tion of GFAP
+/EGFP
+ cells expressed Ki-67 (Fig. S2C) while in
total 8.8%62.1% of EGFP
+ cells were positive for this marker
(Fig. 4D).
Since it has been demonstrated previously that polydendrocytes
can give rise to neurons in vitro and after their transplantation into
the hippocampus [7,23], we examined EGFP
+ cells for the
expression of DCX, a marker of newly derived neurons and
neuroblasts. Surprisingly, we found that almost 5.0%61.9% of
EGFP
+ cells (Fig. 4D) expressed DCX 7 days after MCAo. The
expression of DCX was localized in the cell bodies as well as in the
short processes (Fig. 3I, S2D). Additionally, we also found the
expression of the transcription factor Pax-6 in several EGFP
+ cells
3 and 7 days after MCAo (Fig. S3A). This transcription factor is
known to drive glial cells to adopt a neuronal phenotype [24]. To
exclude the possibility that DCX
+/EGFP
+ cells in the ischemic
border might originate from the neurogenic region in the
subventricular zone (SVZ), we also analyzed in detail the
expression of EGFP in this area. In agreement with previously
published studies [10,25], we never observed the co-expression of
EGFP with other than polydendrocytic markers in the SVZ and,
moreover, the density of EGFP
+ cells in the lateral part of the SVZ
was lower than in the surrounding nervous tissue (Fig. 3C).
Moreover, we also tested if EGFP
+ cells expressed some markers of
reactive microglia after MCAo; however, we never detected any
expression of CD11b (Fig. S3B) or Iba-1 in EGFP
+ cells (Fig. S3C).
Further analyses of ischemic brains 14 days after MCAo
revealed that the number of EGFP
+ cells was still significantly
Figure 2. Focal cerebral ischemia leads to a marked increase in
the number of EGFP
+ cells around the ischemic lesion 7 days
after MCAo. A, A coronal brain section stained with triphenyltetra-
zolium chloride indicates the volume of ischemic tissue (white color) 7
days after MCAo. The boxed area in A is shown in higher magnification
in B. B1–B2, An overview image showing glial fibrillary acidic protein
(GFAP) overexpression around the ischemic region. B3,T y p i c a l
localization and a high number of enhanced green fluorescent protein
positive (EGFP
+) cells around the ischemic core 7 days after MCAo. Note
that few EGFP
+ cells were found directly in the ischemic tissue. Scale
bars, 50 mm.
doi:10.1371/journal.pone.0036816.g002
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3)
and that they represented 9.3%60.4% of all DAPI
+ cells (Fig. 4A4,
C; p,0.001). Immunohistochemical staining for NG2 revealed its
high expression at the lesion border, but only 26.5%62.8% of
EGFP
+ cells expressed this proteoglycan (Fig. 3J). The number of
GFAP
+/EGFP
+ cells was slightly decreased compared to 7 days
after MCAo, but still 13.7%61.2% of EGFP
+ cells expressed
GFAP (Fig. 4D). Furthermore, these cells seemed to have a more
developed phenotype, based on their strong expression of the
astrocyte-specific marker GLAST (Fig. 3K). The number of
proliferating EGFP
+ cells declined and reached the proliferation
rate of the controls, and only 1.2%60.4% of EGFP
+ cells
expressed nestin (Fig. 4D). On the other hand, we still detected a
large number of DCX
+/EGFP
+ cells comprising 8.9%61.6% of
all EGFP
+ cells (Fig. 4D). Concurrently, in these cells immuno-
histochemistry revealed the localization of DCX protein predom-
inantly in the processes, which were more developed than those
observed 7 days after MCAo (Fig. 3L).
In brain sections obtained one month after MCAo we detected
only rarely the co-expression of EGFP with markers of mature
neurons. There were only a few EGFP
+/NeuN
+ cells in the
vicinity of the ischemic lesion (data not shown); however, we also
found several DCX
+/EGFP
+ cells expressing the apoptotic marker
caspase-3 (Fig. S3D).
In addition, we examined brain sections from all time points for
the oligodendrocytic marker APC; however, the number of
APC
+/EGFP
+ cells was very low in the proximity of the ischemic
region, therefore immunohistochemical quantification was not
carried out.
In summary, a detailed analysis of the ischemic border between
7 and 30 days after MCAo revealed that polydendrocytes can
contribute to the generation of reactive astrocytes and, moreover,
Figure 3. Enhanced green fluorescent protein positive (EGFP
+) cells express markers of astrocytes and neuronal precursor cells in
the dorsal cortex after ischemia. A, EGFP
+ cells in sham-operated mice (control) expressed a high level of NG2 proteoglycan in the majority of
processes. White arrows highlight several examples. B, Virtually no EGFP
+ cells in the dorsal control cortex were positive for glial fibrillary acidic
protein (GFAP). C, Low density of EGFP
+ cells in the subventricular zone (SVZ). EGFP
+ cells were never labeled for doublecortin (DCX) in the SVZ of
control brains or those after ischemia, which indicates the absence of polydendrocytes from the process of adult neurogenesis; LV, lateral ventricle. D,
Three days after MCAo the number of EGFP
+ cells is significantly increased when compared to controls. Moreover, a large number of EGFP
+ cells
expressed markers of proliferating cells – nestin (E) and Ki-67 (F). G, EGFP
+ cells were present at high density seven days after MCAo; however, only a
small subpopulation of them expressed NG2 proteoglycan. H, Some EGFP
+ cells were positive for the astrocytic marker GFAP. I, Starting 7 days after
MCAo some scattered cells expressed DCX in their cell bodies and processes. J, Fourteen days after MCAo only a small subpopulation of EGFP
+ cells
expressed NG2 proteoglycan. K, EGFP
+ cells expressing glutamate/aspartate transporter (GLAST), a marker of mature astrocytes. L, A subpopulation of
EGFP
+ cells displaying polarized and highly developed processes, which were positive for DCX. Scale bars, 50 mm.
doi:10.1371/journal.pone.0036816.g003
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neuronal precursor cells, probably due to the influence of growth
factors near the ischemic tissue.
Polydendrocytes do not change phenotype in the
contralateral hemisphere of ischemic animals
Concurrently, we examined the contralateral uninjured hemi-
sphere for the number of EGFP
+ cells and the expression of the
studied markers at all time points after MCAo. Three days after
MCAo we found 1806661951 EGFP
+ cells/mm
3, which repre-
sented 7.3%60.8% of all DAPI
+ cells in the dorsal contralateral
cortex. This number was significantly higher compared to
controls, and the increased quantity of EGFP
+ cells was
maintained 7 days after MCAo as well (Fig. 4C; p,0.05). To
determine the phenotype of the EGFP
+ cells in the contralateral
hemisphere, we analyzed the brain sections for all of the studied
markers. We found no significant changes in the expression of cell
type-specific markers in EGFP
+ cells compared to controls with
Figure 4. Quantification of the changes in the number of enhanced green fluorescent protein positive (EGFP
+) cells and in the
expression of markers typical for glia, neurons and proliferating cells evoked by MCAo. A, Brain sections showing the increasing number
and different distribution of EGFP
+ cells 3, 7 and 14 days after MCAo (A2, A3, A4) when compared to controls (A1). Borders of the ischemic tissue are
highlighted with the dashed lines. Scale bars, 50 mm. B, Schematic figure of coronal slices of the ipsilateral and contralateral hemispheres depicting
the size and localization of tissue injury 7 days after MCAo (grey region), together with the highlighted regions used for immunohistochemical
quantification (yellow squares) in both hemispheres; Cx, cortex; Cc, corpus callosum. C, Bar graph showing the quantification of EGFP
+ cell numbers
per 1 mm
3 in the ipsilateral and contralateral hemispheres in control mice and after MCAo. D, Graph showing the percentage of EGFP
+ cells
expressing markers of polydendrocytes (NG2), proliferating cells (Ki-67, nestin), astrocytes (glial fibrillary acidic protein, GFAP) and neuronal precursor
cells (doublecortin, DCX) in controls and after MCAo. Asterisks indicate significant differences between control cortex and post-ischemic cortex;* ,
p,0.05; ***, p,0.001.
doi:10.1371/journal.pone.0036816.g004
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found that Ki-67 was expressed by 9.262.8% of all EGFP
+ cells 3
days after MCAo, which was a significantly higher percentage
than that found in controls (p,0.05). Interestingly another
proliferation marker, PCNA, was expressed by 51.9% of EGFP
+
cells. Moreover, some EGFP
+ cells expressing low levels of nestin
were found in the contralateral hemisphere 3 days after MCAo
(data not shown).
Polydendrocytes respond to ischemia with significant
changes in their electrophysiological properties
Based on immunohistochemical staining, we found that
polydendrocytes, besides their self-renewal, give rise to a large
population of astrocytes, but also to neuronal precursor cells. Next,
we were interested to determine what electrophysiological
properties polydendrocytes and their progeny display after MCAo.
Using the patch-clamp technique in the whole cell configura-
tion, we initially determined the electrophysiological phenotype of
EGFP
+ cells in control brains. Intracellular staining with a
fluorescent dye revealed that many EGFP
+ cells had several
radially oriented primary and secondary processes, resembling the
multi-process morphology typical of polydendrocytes, as described
previously [26]. Post-recording immunohistochemical analysis
confirmed that these EGFP
+ cells are positive for PDGFaR and
NG2 (Fig. 5a1). In agreement with previous findings [27], we
never observed dye-coupling between individual NG2
+/EGFP
+
cells in controls or after MCAo. As expected, electrophysiological
recordings revealed a complex current pattern typical of a
polydendrocytic population, i.e., they displayed time- and
voltage-independent K
+ conductance together with KDR,K A
and KIR currents in controls [28] (Fig. 5A). Their average RMP
was 277.561.3 mV (n=22), Rm was 121.1610.7 MV and Cm
was 9.560.8 pF. Current densities were 17.566.5 pA/pF for KIR
currents, 8.162.3 pA/pF for KDR currents and 12.463.0 pA/pF
for KA currents (Table 2.). Cells displaying a complex current
pattern represented 81.5%69.9% of all measured EGFP
+ cells in
the control cortex (Fig. 6E).
After MCAo we found EGFP
+ cells with a complex current
pattern at all studied time points; however, their number, passive
membrane properties and current densities were markedly
changed when compared to controls. Three days after MCAo
EGFP
+ cells displaying a complex current pattern had a
significantly increased Rm (p,0.01), which accords well with the
significantly decreased CD of KIR currents and time- and voltage-
independent K
+ conductance when compared to controls
(Table 2.; p,0.01). On the other hand, the CD of KDR currents
was significantly increased when compared to controls (p,0.001).
These changes in the membrane properties have been shown to
reflect the high proliferative activity of polydendrocytes soon after
ischemia [13,29], which is also in good correlation with the
increased expression of Ki-67 and nestin in EGFP
+ cells 3 days
after ischemia. Interestingly, in this early phase after ischemia we
also detected TTX-sensitive Na
+ currents with a low CD of
3.661.3 pA/pF in these cells (8 from 35 cells, Fig. 6A); their
presence probably contributed to the significantly depolarized
RMP when compared to controls (p,0.05) [13,27]. Since Na
+
currents in grey matter polydendrocytes are detected predomi-
nately in the early postnatal stages [27], we might conclude that
polydendrocytes early after ischemia resemble the immature
developing stages of polydendrocytes [23]. Post-recording immu-
nohistochemical identification 3 days after MCAo revealed their
positivity for NG2 and nestin (Fig. 6a1). Seven days after MCAo
the percentage of EGFP
+ cells with a complex current pattern had
significantly decreased to 23.4%66.9% (p,0.001) (Fig. 6E). These
cells were depolarized and, moreover, they had significant
increased CD of KDR currents when compared to controls
(p,0.001). Fourteen days after MCAo we found a further
significant decrease in the quantity of the EGFP
+ cells with a
complex current pattern when compared to controls. Only
20.9%66.1% (p,0.001) of all measured EGFP
+ cells revealed a
complex current pattern (Fig. 6E). These cells had a significantly
depolarized RMP (p,0.05), but no other significant differences in
their membrane properties were found when compared to
controls. These cells always expressed only polydendrocytic
markers, such as NG2 and PDGFaR, 7 and 14 days after MCAo.
Taken together, our electrophysiological analyses of polyden-
drocytes during the post-ischemic period revealed significant
changes in their membrane properties 3 days after MCAo that
coincided with their increased proliferation and their declining
incidence 7 and 14 days after MCAo.
Polydendrocytes differentiate into cells with the
functional properties of astrocytes after ischemia
During the post-ischemic period a subpopulation of EGFP
+ cells
displayed a current profile with predominant high time- and
voltage-independent non-decaying K
+ conductance, a so-called
passive current pattern (Fig. 6B). These cells were detected in all
post-ischemic periods, and their passive membrane properties as
well as their current densities did not significantly differ at the
studied time points after MCAo (Table 3.). Fourteen days after
MCAo these cells had an RMP of 247.561.0 mV, Rm was
135.368.0 MV and Cm reached 7.560.6 pF (n=33). The
current density reached 0.560.3 pA/pF for KIR and
8.063.3 pA/pF for KDR currents, which was completely blocked
Figure 5. Enhanced green fluorescent protein positive (EGFP
+)
cells in the cortex of sham-operated mice are NG2
+ polyden-
drocytes displaying a complex current pattern. A, Polydendro-
cytic current pattern in controls measured after depolarizing the cell
membrane from a holding potential of 270 mV to +40 mV and
hyperpolarizing to 2160 mV (see the inset, bottom). Polydendrocytes
showed a complex current pattern, i.e., time- and voltage-independent
K
+ currents, KDR,K A and KIR currents. The dashed line marks zero current.
a1–a4, Polydendrocyte expressing EGFP in control cortex (a2), loaded
with Alexa Fluor 594 hydrazid during patch-clamp measurement (a3),
subsequently stained with an antibody directed against NG2 proteo-
glycan (a4). Scale bars, 50 mm.
doi:10.1371/journal.pone.0036816.g005
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polydendrocytes measured 3 days after MCAo in response to cell membrane depolarization from a holding potential of 270 mV to +40 mV and
hyperpolarization to 2160 mV (see the inset, bottom). Polydendrocytes showed a current pattern with KDR,K A, small KIR currents and fast activating
Na
+ inward currents in a few cells 3 days after MCAo. Zero current is marked by the dashed line. a1–a4, Polydendrocyte expressing enhanced green
fluorescent protein (EGFP) 3 days after MCAo (a2) loaded with Alexa Fluor 594 hydrazid during patch-clamp measurement (a3) subsequently stained
with an antibody directed against nestin (a4). White arrow indicates the recorded cell. Scale bars, 50 mm. B, Current pattern of EGFP
+ astrocytes 7 days
after MCAo recorded using the same protocol as in (A). EGFP
+ astrocytes showed a passive current pattern, i.e., time- and voltage-independent non-
decaying K
+ currents, with only small voltage activated K
+ currents. Zero current is marked by the dashed line. b1–b4, Astrocytes expressing EGFP 7
days after MCAo (b2) loaded with Alexa Fluor 594 hydrazid during patch-clamp measurement (b3), subsequently stained with an antibody directed
against glial fibrillary acidic protein (GFAP, b4), a marker of astrocytes. Note dye coupling (b3) between EGFP
+ cells with a passive current pattern
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ences in the percentage of these cells in the post-ischemic periods.
EGFP
+ cells with a passive current pattern were never detected in
controls, and their distribution increased with time after ischemia.
Their number was significantly increased 7 and 14 days after
MCAo when compared to controls; they represented
48.4%68.5% (p,0.01) and 49.3%610.2% (p,0.01), respective-
ly, of all measured cells (Fig. 6E). Some of them expressed nestin,
Ki-67 or GFAP 3 days after MCAo; however, in the later phases
after MCAo only GFAP (Fig. 6b1) or GLAST were detected by
immunohistochemical post-recording identification. Starting 7
days after MCAo intracellular staining with a fluorescent dye
showed that some EGFP
+ cells with a passive current pattern were
dye-coupled to other EGFP
+ or EGFP
2 cells (Fig. 6b3). We can
conclude that a certain subpopulation of newly-derived cells of
polydendrocyte origin expresses astrocytic markers and these cells
also display membrane properties typical of reactive astrocytes.
Polydendrocytes also differentiate into cells with the
functional properties of immature neuronal precursor
cells after ischemia
In agreement with our immunohistochemical analysis, we also
detected a subpopulation of EGFP
+ cells that expressed a current
profile that resembled that of neuronal precursor cells (Fig. 6c).
These cells were detected 7 and 14 days after MCAo, and their
passive membrane properties as well as the current densities of
their voltage activated channels did not significantly differ between
these two time points. Seven days after MCAo these cells had an
RMP about 258.265.0 mV, their Rm was 840.46144.9 MV and
Cm was 5.260.9 pF (n=6). The current densities reached
1.361.3 pA/pF for KIR currents, 34.766.0 pA/pF for KDR
currents and 17.962.0 pA/pF for KA currents. These cells also
expressed TTX-sensitive Na
+ currents, but with a significantly
higher CD (39.5610.2 pA/pF, p,0.01) (Table 4.) and clearly
different kinetics when compared to polydendrocytes with Na
+
currents 3 days after MCAo. The Na
+ currents in neuronal
precursor cells displayed significantly faster activation after
depolarization steps when compared to Na
+ currents in poly-
dendrocytes and, in addition, these currents were activated at a
significantly lower voltage threshold (218.065.8 mV) than in
polydendrocytes (2.964.2 mV, p,0.05). The percentage of
neuronal precursor cells reached 9.4%63.1% of all measured
cells 7 days after MCAo and 4.5%64.0% 14 days after MCAo
(Fig. 6E). Post-recording immunohistochemical identification
confirmed DCX expression in EGFP
+ neuronal precursor cells
(Fig. 6c1).
After ischemia only a small population of
oligodendrocytes in the cortex arises from
polydendrocytes
Furthermore, in some EGFP
+ cells we have recorded time- and
voltage-independent K
+ currents decaying during the duration of
the voltage pulse, a typical current pattern of oligodendrocytes
[30] (Fig. 6D). These cells were present at all analyzed time points,
and their electrophysiological properties and quantity did not
significantly change after MCAo when compared to controls
(Fig. 6E). Seven days after MCAo they had an RMP of
254.564.9 mV, Rm was 815.86120.6 MV and Cm was
9.863.9 pF (n=6). The current densities reached 4.464.4 pA/
pF for KIR currents, 11.665.2 pA/pF for KDR currents and
6.563.6 pA/pF for KA currents. These cells were positive for APC
or Olig2 (Fig. 6d1) as revealed by post-recording immunohisto-
chemical identification.
Certain subpopulation of EGFP
+ cells in the ischemic
cortex are pericytes
Finally, the last identified subpopulation based on electrophys-
iological properties comprised cells with negligible voltage
activated or time- and voltage-independent K
+ currents and was
present in both control and post-ischemic brains. These cells did
not significantly differ in their electrophysiological properties or
quantity (Fig. 6E) at any studied time points. Post-recording
immunohistochemical identification showed that they did not
express common neuronal or glial markers; however, we were able
to occasionally detect PDGFbR expression on their surface, which
classified them as pericytes.
compared to EFGP
+ cells with a complex current pattern in A (a3). Scale bars, 50 mm. C, Current pattern of EGFP
+ neuronal precursor cells 7 days after
MCAo measured with the same protocol as in (A). EGFP
+ neuronal precursor cells displayed outwardly rectifying K
+ currents (KDR,K A currents)
together with higher Na
+ currents when compared to polydendrocytes. c1–c4, Neuronal precursor cells expressing EGFP 7 days after MCAo (c2),
loaded with Alexa Fluor 594 hydrazid during patch-clamp measurement (c3), subsequently stained with an antibody directed against doublecortin
(DCX, c4), a marker of newly-derived neuronal precursor cells. Scale bars, 50 mm. D, Current pattern of EGFP
+ oligodendrocytes 7 days after MCAo
measured with the same protocol as in (A). EGFP
+ oligodendrocytes displayed time- and voltage-independent K
+ currents decaying during the
duration of the voltage pulse. d1–d4, Oligodendrocytes expressing EGFP 7 days after MCAo (d2) loaded with Alexa Fluor 594 hydrazid during patch-
clamp measurement (d3), subsequently stained with an antibody directed against Olig2 (d4). E, Graph showing the percentage of EGFP
+ cell with
distinct current patterns. Asterisks indicate significant differences between control cortex and post-ischemic cortex; **, p,0.01; ***, p,0,001.
doi:10.1371/journal.pone.0036816.g006
Table 2. Electrophysiological properties of EGFP
+ cells with a
complex current pattern.
Control 3 d MCAo 7 d MCAo 14 d MCAo
RMP (mV) 277.561.3 269.562.1 (*) 259.565.2 (***) 265.263.1 (*)
Rm (MV) 121.1610.7 525.3688.4 (**) 372.7642.5 309.3639.7
Cm (pF) 9.560.8 8.960.8 7.260.9 8.861.3
KIR (pA/pF) 17.566.5 3.360.8 (**) 9.661.3 7.061.3
KDR (pA/pF) 8.162.3 29.663.4 (***) 31.263.6 (***) 8.361.9
KA (pA/pF) 12.463.0 14.762.1 11.763.0 14.663.4
Na (pA/pF) 0.060.0 3.561.3 (*) 0.060.0 0.060.0
n2 23 5 1 5 1 4
% 81.069.9 60.066.6 23.466.9 (***) 20.966.1 (***)
RMP, resting membrane potential; Rm, membrane resistance; Cm, membrane
capacitance; KIR, current density of inwardly-rectifying K
+ currents; KDR, current
density of voltage-gated delayed outwardly-rectifying K
+ currents; KA, current
density of the fast activating and inactivating outwardly-rectifying K
+ currents;
Na, current density of Na
+ currents; n, number of measured cells; %, percentage
of the cell type;
*, p,0.05;
**, p,0.01;
***, p,0.001.
doi:10.1371/journal.pone.0036816.t002
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In the present study, we used mice with constitutively active Cre
driven by the NG2-promoter that, after breeding with a reporter
strain, allow fate mapping of a large population of polydendro-
cytes. In accordance with previous studies [10], we detected the
generation of oligodendrocytes in the uninjured adult brain;
however, in contradiction to some earlier reports [9,18], our study
did not confirm the generation of astrocytes and therefore excludes
polydendrocytes as multipotent cells in the healthy adult brain.
After detailed characterization of the phenotype of EGFP
+ cells
in the healthy brain, the mice were subjected to focal cerebral
ischemia, which triggered dramatic changes in the morphology,
number and phenotype of EGFP
+ cells. The number of EGFP
+
cells after ischemia was significantly increased; the cells displayed
heterogeneous morphology and expressed markers of astrocytes
and neuronal precursor cells. Moreover, polydendrocyte multi-
potency was confirmed by detailed electrophysiological analysis,
which also proved the generation of astrocytic and neuronal
precursor phenotypes from EGFP
+ cells after ischemia.
Polydendrocytes are unipotent cells in the healthy adult
brain
A number of recent studies have shown the importance of
selecting an appropriate polydendrocytic marker as a Cre
promoter. In our study we used NG2, as a generally accepted
marker of polydendrocytes and, moreover, this proteoglycan is not
down-regulated after injury as in the case of PDGFaR [12].
Although NG2 and PDGFaR are strongly co-expressed in control
cells, more distinct polydendrocytic subpopulations can arise after
ischemia.
We used the NG2creBAC mice strain with constitutively active
Cre expression and a high recombination rate, in which a large
polydendrocyte population and their progeny express EGFP. This
enabled us to analyze a larger sample of EGFP
+ cells before and
after ischemia than in mice with an inducible form of Cre with low
recombination efficiency. Although inducible Cre brings the
advantage of labeling a cohort of cells with a currently expressed
marker, our analysis proved that we had a well characterized cell
population clearly restricted to only polydendrocytes, oligoden-
drocytes and pericytes before ischemia in the adult cortex.
Polydendrocytes expressing NG2 and EGFP displayed immuno-
cytochemical and electrophysiological properties that suggested
the absence of any additional subpopulations of polydendrocytes
in the adult cortex. This finding is in agreement with study [31],
where was detected a uniform population of polydendrocytes in
the adult hippocampus.
Polydendrocytes respond to ischemia by increased
proliferation
After ischemia we detected a significantly increased number of
EGFP
+ cells on the ischemic lesion edge at all studied time points,
a phenomenon already described after a stab wound [11,15],
cryoinjury [32], in experimental autoimmune encephalomyelitis
[33] or focal demyelination [34]. Based on the extensive
proliferation of polydendrocytes in the early stages after injury (a
3-fold higher number of Ki-67
+/EGFP
+ cells and a 2.9-fold higher
number of PCNA
+/EGFP
+ cells 3 days after MCAo when
compared to controls), we assume that this increased number of
EGFP
+ cells is caused by the generation of new EGFP
+ cells from
existing polydendrocytes. However, we cannot entirely exclude
polydendrocyte migration from the surrounding tissue to the site of
injury. Another eventuality is that other cell types began to
transiently express NG2, as was shown, for example, in the case of
microglia cells. Although several recent studies have reported the
low expression of NG2 in resting microglia, we never detected
EGFP in these CD11b
+/Iba-1
+ cells in the control brain [35].
Moreover, the transiently increased expression of NG2 has been
shown in activated microglia cells after several types of injury [35–
37]; on the other hand, other studies exclude the possibility of
NG2 expression in these cells [31,38,39]. In our study, we never
detected EGFP
+ cells that displayed any microglial immunohisto-
chemical or electrophysiological properties at any studied time
point after MCAo. This phenomenon indicates that microglia cells
after injury really do not activate the NG2 promoter or that a
weak or short, transient activation of the CSPG4 promotor in the
adult brain is not sufficient to trigger the expression of EGFP in
other cells types, thus confirming that newly-derived EGFP
+ cells
originate from pre-ischemic EGFP
+ cells.
Table 3. Electrophysiological properties of EGFP
+ cells with a
passive current pattern.
3 d MCAo 7 d MCAo 14 d MCAo
RMP (mV) 256.064.4 252.862.7 247.561.0
Rm (MV) 165.0613.0 168.468.3 135.368.0
Cm (pF) 8.460.9 9.761.6 7.560.6
KIR (pA/pF) 2.761.3 2.861.1 0.560.3
KDR (pA/pF) 10.563.0 9.061.9 8.063.3
KA (pA/pF) 0.060.0 0.060.0 0.060.0
Na (pA/pF) 0.060.0 0.060.0 0.060.0
n1 8 3 1 3 3
% 31.067.6 48.468.5 49.3610.2
RMP, resting membrane potential; Rm, membrane resistance; Cm, membrane
capacitance; KIR, current density of inwardly-rectifying K
+ currents; KDR, current
density of voltage-gated delayed outwardly-rectifying K
+ currents; KA, current
density of the fast activating and inactivating outwardly-rectifying K
+ currents;
Na, current density of Na
+ currents; n, number of measured cells; %, percentage
of the cell type.
doi:10.1371/journal.pone.0036816.t003
Table 4. Electrophysiological properties of EGFP
+ neuronal
precursor cells.
7 d MCAo 14 d MCAo
RMP (mV) 258.265.0 262.769.3
Rm (MV) 840.46144.9 1189.76631.9
Cm (pF) 5.260.9 6.960.9
KIR (pA/pF) 1.361.3 0.060.0
KDR (pA/pF) 34.7066.0 46.165.8
KA (pA/pF) 17.962.0 15.762.5
Na (pA/pF) 39.5610.2 21.5612.0
n6 3
%9 . 4 63.1 4.564.1
RMP, resting membrane potential; Rm, membrane resistance; Cm, membrane
capacitance; KIR, current density of inwardly-rectifying K
+ currents; KDR, current
density of voltage-gated delayed outwardly-rectifying K
+ currents; KA, current
density of the fast activating and inactivating outwardly-rectifying K
+ currents;
Na, current density of Na
+ currents; n, number of measured cells; %, percentage
of the cell type.
doi:10.1371/journal.pone.0036816.t004
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NG2 at the lesion site in the later phases after ischemia, which
accords well with previously published results [40]; however, the
total number of EGFP
+ cells with detectable NG2 expression
decreased. This phenomenon can be explained by the increased
release of soluble NG2 form from many cell types into the
extracellular space [40] and, concurrently, by differentiating of
NG2
+ polydendrocytes into another cell type.
Genetic fate mapping enabled us to determine the functional
properties of polydendrocytes even in the later phases after
ischemia, when it is extremely difficult to perform patch-clamp
measurements of newly-derived cells in the gliotic scar full of
reactive astrocytes and microglia. We found that polydendrocytes
responded to ischemia with marked changes in their electrophys-
iological properties, especially in the early phases after ischemia.
However, in the late phases after ischemia their membrane
properties were comparable to those of controls, indicating the
rapid recovery of polydendrocytic electrophysiological properties
to the pre-ischemic state.
Polydendrocytes display multipotent differentiation
potential after ischemia
Based on immunohistochemical analysis, ,75% of EGFP
+ cells
did not express NG2 14 days after MCAo and electrophysiological
analysis revealed ,80% of EGFP
+ cells with a current pattern
distinct from that of polydendrocytes. The expression of GFAP,
GLAST or vimentin together with a passive current pattern and
dye-coupling in a large subpopulation of EGFP
+ cells evidenced
that polydendrocytes can give rise to reactive astrocytes after
ischemia. The generation of a reactive astrocyte subpopulation
from polydendrocytes was already shown in models of cryoinjury
[32], stab wound injury, experimental autoimmune encephalo-
myelitis or focal demyelination. However, in the majority of these
injuries the generation of new astrocytes was limited and
represented ,8% of EGFP
+ cells, and their number declined in
the later phases after injury. In our study we detected ,17% of
EGFP
+ cells with an astrocytic phenotype 7 days after ischemia,
and their number only slightly decreased in the later phases after
ischemia. This discrepancy is probably caused by using different
injury models. In addition, the majority of studies employed rather
mild types of cortical injuries or models of demyelination in the
spinal cord; in contrast, we used a model of severe ischemic brain
injury, in which the stronger involvement of repair processes and
higher levels of growth factors could play an important role,
resulting in greater differentiation of polydendrocytes into
astrocytes. Moreover, we analyzed in detail the electrophysiolog-
ical properties of newly-derived astrocytes. These cells had a
passive current profile with 4-AP sensitive KDR currents, which
were further decreased in the later phases after ischemia. Our
results are in good agreement with previously published electro-
physiological analyses of reactive astrocytes after ischemia in the
hippocampus [13] and cortex [41] and show that these newly-
derived astrocytes are comparable with other reactive astrocyte
populations in the later phases after ischemia.
Importantly, we also identified cells of polydendrocyte origin
that displayed the immunohistochemical and electrophysiological
properties of neuronal precursor cells and comprised ,9% of
EGFP
+ cells 7 days after ischemia. Although recent studies
described DCX expression and the differentiation of PDGFaR
+ or
PLP
+ cells into neurons in the healthy adult brain, this
phenomenon was always strictly localized only in the piriform
cortex [8,10]. Nevertheless, in our study we did not detect any
EGFP
+/DCX
+ cells in any brain regions including the SVZ of
sham-operated mice. After ischemia, some EGFP
+/DCX
+ cells
displayed Na
+ currents with a significantly higher CD and
markedly different kinetics when compared to polydendrocytes,
together with high membrane resistance, which is a typical feature
of immature neuroblasts [42]. Since it is relatively easy to force
polydendrocytes in vitro to differentiate into neurons [5–7], a
suitable mixture of growth factors and morphogenes released at
the lesion site can probably also promote this phenomenon in vivo.
However, detailed analysis of these cells in the later phases after
ischemia revealed that these cells were probably incapable of
surviving and maturing into cells with a more developed neuronal
phenotype. This assumption is based on our observation of the
strong expression of caspase-3 in several EGFP
+/DCX
+ cells, and
their inability to survive in the damaged ischemic region was also
described previously in the newly-derived SVZ neuroblasts
migrating into the site of injury after stroke [43]. We described
the generation of neuronal precursor cells in mature, but still very
young mice; however, we must assume that multipotency and the
ability to differentiate into different cell types is strongly correlated
with age. Many studies describing the multipotency of polyden-
drocytes were performed using postnatal or very young animals
[5,6], so the ability to produce cells of the neuronal lineage could
be strongly suppressed in older mice. The same scenario probably
applies to the ability of polydendrocytes to give rise to astrocytes in
the healthy brain. As was shown recently, polydendrocytes in the
embryonic brain differentiate into astrocytes, but this capability is
not maintained into adulthood [44].
In our study we also detected EGFP
+ oligodendrocytes before
and after ischemia; however, in comparison to the large number of
other newly-derived cell types, newly generated oligodendrocytes
did not comprise the major cell population that originated from
polydendrocytes after ischemia. The low number of EGFP
+
oligodendrocytes in the gray matter of the healthy brain is in
agreement with previous studies describing the generation of
oligodendrocytes predominantly in the white matter [10,45].
Nonetheless, we also detected a low number of oligodendrocytes
after ischemia, which accords well with recent findings [16], but is
in contrast to other recently published studies [10,15]. Important-
ly, we employed a more severe model of injury in which high levels
of glutamate are released and which results in extensive
neuroinflammation, and this might be an adverse environment
for oligodendrocyte survival, which are strongly susceptible to
excitotoxic death [46].
The last type of NG2
+/EGFP
+ cells found in uninjured and
ischemic brains are the often overlooked pericytes. Since these
cells express both NG2 and PDGFaR [47], they are probably
involved in every fate mapping study that uses these proteins as
markers of polydendrocytes. In our study pericytes were identified
based on PDGFbR expression and the absence of any voltage
activated currents; fourteen days after ischemia, their number
almost doubled when compared to controls. Although we did not
perform a detailed immunohistochemical analysis, there was an
evident increase in the number of EGFP
+ cells that displayed a
pericytic morphology and lined vessels in the vicinity of the
ischemic lesion. Of note, a recent study described a massive
proliferation of a distinct subclass of pericytes and their
participation in scar tissue formation following spinal cord injury
[48]. In contrast to these findings, we did not detect any EGFP
+
pericytes inside the ischemic core, which might be caused by our
employing a different model of injury in a different CNS region.
Moreover, the existence of several types of pericytes was described
previously [49,50], therefore the NG2
+ pericytes labeled in our
study could have a different role following ischemic injury.
Recently, the wide differentiation potential of pericytes was
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to the generation of different cell phenotypes after ischemia.
It is probable that polydendrocytes close to the ischemic region
are exposed to factors and signals that indicate that tissue
homeostasis and the integrity of the blood–brain barrier has been
disrupted. Which components present in the serum, or which
signals released from neural and non-neural elements are
responsible for their increased proliferation and/or fate decision,
remains to be determined. Nevertheless, these factors are likely to
activate the Notch-1 pathway, as suggested by its up-regulation in
reactive glial cells after injury [52–54]. A similar up-regulation was
described for bone morphogenetic factor in the post-injury niche,
and this factor was shown to drive the differentiation of
polydendrocytes into astrocytes, while simultaneously its antago-
nist Noggin reverses this process [55]. A very important role in
controlling the proliferation and differentiation of polydendrocytes
is also played by the b-catenin signaling pathway, which is strongly
activated after cortical injury [56]. It seems that information about
massive ischemic injury is delivered to polydendrocytes in a large
part of the CNS; however, only the directly exposed subpopulation
of polydendrocytes responds to this pathology not only by
proliferation, but also by differentiation into another cell types.
Supporting Information
Figure S1 Enhanced green fluorescent protein (EGFP) is
expressed also in pericytes, but not in microglia in the
control dorsal cortex of NG2creBAC:ZEG mice. A,
Immunostaining for PDGFbR in the cortex showing several
PDGFbR
+/EGFP
+ cells with morphology of pericytes. White
arrows highlight several examples. B, Image showing immuno-
staining for microglial marker Iba-1; however, EGFP
+ cells never
express this marker. Scale bars, 50 mm.
(TIF)
Figure S2 Proliferation and multipotency of EGFP
+ cells
after MCAo. A, Immunostaining for PCNA in the cortex
showing almost all EGFP
+ cells expressing this proliferation
marker 3 days after MCAo. White arrows highlight several
examples. B, Image showing all channels from Fig. 3H and
orthogonal projection of this EGFP
+/GFAP
+ cell 7 days after
MCAo. C, Several EGFP
+/GFAP
+ cells proliferate 7 days after
MCAo based on Ki-67 expression. D, Image showing in detail
EGFP
+ cells with strong expression of doublecortin (DCX) 7 days
after MCAo. Scale bars, 50 mm.
(TIF)
Figure S3 Immunohistochemical properties of EGFP
+
cells after MCAo. A, Immunostaining for Pax-6 in the cortex
showing several EGFP
+ cells expressing this transcription factor 7
days after MCAo. White arrows highlight several examples. B,
Image showing a CD11b staining on EGFP
+ cells 7 days after
MCAo. The ischemic region is filled with activated microglia cells;
however, no microglia expressed EGFP. C, Image showing a Iba-1
staining on EGFP+ cells 7 days after MCAo, also this marker of
microglia and macrophages was not co-expressed with EGFP. D,
Several EGFP
+/DCX
+ cells expressed apoptotic marker caspase-3
14 days after MCAo. Scale bars, 50 mm.
(TIF)
Acknowledgments
The authors would like to thank to Helena Pavlikova for excellent technical
assistance. We also thank James Dutt for helpful comments and
suggestions.
Author Contributions
Conceived and designed the experiments: PH MA. Performed the
experiments: PH HP DD MF. Analyzed the data: PH HP. Wrote the
paper: PH MA.
References
1. Tian D-S, Dong Q, Pan D-J, He Y, Yu Z-Y, et al. (2007) Attenuation of
astrogliosis by suppressing of microglial proliferation with the cell cycle inhibitor
olomoucine in rat spinal cord injury model. Brain Res 1154: 206–214.
2. Yang Y, Jalal FY, Thompson JF, Walker EJ, Candelario-Jalil E, et al. (2011)
Tissue inhibitor of metalloproteinases-3 mediates the death of immature
oligodendrocytes via TNF-a/TACE in focal cerebral ischemia in mice.
J Neuroinflammation 8: 108.
3. Pettigrew LC, Kindy MS, Scheff S, Springer JE, Kryscio RJ, et al. (2008) Focal
cerebral ischemia in the TNFalpha-transgenic rat. J Neuroinflammation 5: 47.
4. Nishiyama A (2007) Polydendrocytes: NG2 cells with many roles in development
and repair of the CNS. Neuroscientist 13: 62–76.
5. Kondo T, Raff M (2000) Oligodendrocyte precursor cells reprogrammed to
become multipotential CNS stem cells. Science 289: 1754–1757.
6. Belachew S, Chittajallu R, Aguirre A, Yuan X, Kirby M, et al. (2003) Postnatal
NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and
generate functional neurons. J Cell Biol 161: 169–186.
7. Aguirre A, Chittajallu R, Belachew S, Gallo V (2004) NG2-expressing cells in
the subventricular zone are type C-like cells and contribute to interneuron
generation in the postnatal hippocampus. J Cell Biol 165: 575–589.
8. Guo F, Maeda Y, Ma J, Xu J, Horiuchi M, et al. (2010) Pyramidal Neurons Are
Generated from Oligodendroglial Progenitor Cells in Adult Piriform Cortex.
J Neurosci 30: 12036–12049.
9. Zhu X, Hill RA, Nishiyama A (2008) NG2 cells generate oligodendrocytes and
gray matter astrocytes in the spinal cord. Neuron Glia Biol 4: 19–26.
10. Rivers LE, Young KM, Rizzi M, Jamen F, Psachoulia K, et al. (2008)
PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform
projection neurons in adult mice. Nat Neurosci 11: 1392–1401.
11. Dimou L, Simon C, Kirchhoff F, Takebayashi H, Goetz M (2008) Progeny of
Olig2-Expressing Progenitors in the Gray and White Matter of the Adult Mouse
Cerebral Cortex. J Neurosci 28: 10434–10442.
12. Hampton D, Rhodes K, Zhao C, Franklin R, Fawcett J (2004) The responses of
oligodendrocyte precursor cells, astrocytes and microglia to a cortical stab injury,
in the brain. Neuroscience 127: 813–820.
13. Pivonkova H, Benesova Jana, Benesova J, Butenko O, Chvatal A, et al. (2010)
Impact of global cerebral ischemia on K+ channel expression and membrane
properties of glial cells in the rat hippocampus. Neurochem Int 57: 783–794.
14. Trotter J, Karram K, Nishiyama A (2010) NG2 cells: Properties, progeny and
origin. Brain Res Rev 63: 72–82.
15. Komitova M, Serwanski DR, Richard Lu Q, Nishiyama A (2011) NG2 cells are
not a major source of reactive astrocytes after neocortical stab wound injury.
Glia 59: 800–809.
16. Anderova Miroslava, Vorisek I, Pivonkova H, Benesova Jana, Vargova L, et al.
(2011) Cell death/proliferation and alterations in glial morphology contribute to
changes in diffusivity in the rat hippocampus after hypoxia-ischemia. J Cereb
Blood Flow Metab 31: 894–907.
17. Muskhelishvili L, Latendresse JR, Kodell RL, Henderson EB (2003) Evaluation
of Cell Proliferation in Rat Tissues with BrdU, PCNA, Ki-67(MIB-5)
Immunohistochemistry and In Situ Hybridization for Histone mRNA. Journal
of Histochemistry & Cytochemistry 51: 1681–1688.
18. Zhu X, Bergles DE, Nishiyama A (2008) NG2 cells generate both
oligodendrocytes and gray matter astrocytes. Development 135: 145–157.
19. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, et al. (2008) A
transcriptome database for astrocytes, neurons, and oligodendrocytes: a new
resource for understanding brain development and function. J Neurosci 28:
264–278.
20. Carmichael ST (2005) Rodent models of focal stroke: size, mechanism, and
purpose. NeuroRx: the journal of the American Society for Experimental
NeuroTherapeutics 2: 396–409.
21. Michalczyk K, Ziman M (2005) Nestin structure and predicted function in
cellular cytoskeletal organisation. Histol Histopathol 20: 665–671.
22. Simon C, Go ¨tz M, Dimou L (2011) Progenitors in the adult cerebral cortex: Cell
cycle properties and regulation by physiological stimuli and injury. Glia 59:
869–881.
23. Chen P-H, Cai W-Q, Wang L-Y, Deng Q-Y (2008) A morphological and
electrophysiological study on the postnatal development of oligodendrocyte
precursor cells in the rat brain. Brain Res 1243: 27–37.
24. Heins N, Malatesta P, Cecconi F, Nakafuku M, Tucker KL, et al. (2002) Glial
cells generate neurons: the role of the transcription factor Pax6. Nat Neurosci 5:
308–315.
25. Komitova M, Zhu X, Serwanski DR, Nishiyama A (2009) NG2 cells are distinct
from neurogenic cells in the postnatal mouse subventricular zone. J Comp
Neurol 512: 702–716.
Multipotency of Polydendrocytes after Ischemia
PLoS ONE | www.plosone.org 13 May 2012 | Volume 7 | Issue 5 | e3681626. Nishiyama A, Komitova M, Suzuki R, Zhu X (2009) Polydendrocytes (NG2
cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci 10: 9–22.
27. Xie M, Lynch DT, Schools GP, Feustel PJ, Kimelberg HK, et al. (2007) Sodium
channel currents in rat hippocampal NG2 glia: Characterization and
contribution to resting membrane potential. Neuroscience 150: 853–862.
28. Schools GP, Zhou M, Kimelberg HK (2003) Electrophysiologically ‘‘complex’’
glial cells freshly isolated from the hippocampus are immunopositive for the
chondroitin sulfate proteoglycan NG2. J Neurosci Res 73: 765–777.
29. Knutson P, Ghiani CA, Zhou JM, Gallo V, McBain CJ (1997) K+ channel
expression and cell proliferation are regulated by intracellular sodium and
membrane depolarization in oligodendrocyte progenitor cells. J Neurosci 17:
2669–2682.
30. Chvatal A, Anderova Miroslava, Sykova E (2004) Analysis of K+ accumulation
reveals privileged extracellular region in the vicinity of glial cells in situ.
J Neurosci Res 78: 668–682.
31. Karram K, Goebbels S, Schwab M, Jennissen K, Seifert G, et al. (2008) NG2-
expressing cells in the nervous system revealed by the NG2-EYFP-knockin
mouse. genesis 46: 743–757.
32. Tatsumi K, Takebayashi H, Manabe T, Tanaka KF, Makinodan M, et al.
(2008) Genetic fate mapping of Olig2 progenitors in the injured adult cerebral
cortex reveals preferential differentiation into astrocytes. J Neurosci Res 86:
3494–3502.
33. Tripathi RB, Rivers LE, Young KM, Jamen F, Richardson WD (2010) NG2
Glia Generate New Oligodendrocytes But Few Astrocytes in a Murine
Experimental Autoimmune Encephalomyelitis Model of Demyelinating Disease.
J Neurosci 30: 16383–16390.
34. Zawadzka M, Rivers LE, Fancy SPJ, Zhao C, Tripathi R, et al. (2010) CNS-
Resident Glial Progenitor/Stem Cells Produce Schwann Cells as well as
Oligodendrocytes during Repair of CNS Demyelination. Stem Cell 6: 578–590.
35. Wohl SG, Schmeer CW, Friese T, Witte OW, Isenmann S (2011) In Situ
Dividing and Phagocytosing Retinal Microglia Express Nestin, Vimentin, and
NG2 In Vivo. PLoS ONE 6: e22408.
36. Zhu L, Lu J, Tay SSW, Jiang H, He BP (2010) Induced NG2 expressing
microglia in the facial motor nucleus after facial nerve axotomy. NSC 166:
842–851.
37. Gao Q, Lu J, Huo Y, Baby N, Ling EA, et al. (2010) NG2, a member of
chondroitin sulfate proteoglycans family mediates the inflammatory response of
activated microglia. NSC 165: 386–394.
38. Bulloch K, Miller MM, Gal-Toth J, Milner TA, Gottfried-Blackmore A, et al.
(2008) CD11c/EYFP transgene illuminates a discrete network of dendritic cells
within the embryonic, neonatal, adult, and injured mouse brain. J Comp Neurol
508: 687–710.
39. Nishiyama A, Yu M, Drazba JA, Tuohy VK (1997) Normal and reactive NG2+
glial cells are distinct from resting and activated microglia. J Neurosci Res 48:
299–312.
40. Jones LL, Yamaguchi Y, Stallcup WB, Tuszynski MH (2002) NG2 is a major
chondroitin sulfate proteoglycan produced after spinal cord injury and is
expressed by macrophages and oligodendrocyte progenitors. J Neurosci 22:
2792–2803.
41. Anderova Miroslava, Antonova T, Petrik D, Neprasova Helena, Chvatal A, et
al. (2004) Voltage-dependent potassium currents in hypertrophied rat astrocytes
after a cortical stab wound. Glia 48: 311–326.
42. Lacar (2010) Imaging and recording subventricular zone progenitor cells in live
tissue of postnatal mice. Front Neurosci.
43. Carlen M, Meletis K, Go ¨ritz C, Darsalia V, Evergren E, et al. (2009) Forebrain
ependymal cells are Notch-dependent and generate neuroblasts and astrocytes
after stroke. Nat Neurosci 12: 259–267.
44. Zhu X, Hill RA, Dietrich D, Komitova M, Suzuki R, et al. (2011) Age-
dependent fate and lineage restriction of single NG2 cells. Development 138:
745–753.
45. Kang SH, Fukaya M, Yang JK, Rothstein JD, Bergles DE (2010) NG2+ CNS
Glial Progenitors Remain Committed to the Oligodendrocyte Lineage in
Postnatal Life and following Neurodegeneration. Proc Natl Acad Sci USA 68:
668–681.
46. Matute C, Alberdi E, Domercq M, Sa ´nchez-Go ´mez M-V, Pe ´rez-Samartı ´nA ,e t
al. (2007) Excitotoxic damage to white matter. J Anat 210: 693–702.
47. Richardson WD, Young KM, Tripathi RB, McKenzie I (2011) NG2-glia as
Multipotent Neural Stem Cells: Fact or Fantasy? Proc Natl Acad Sci USA 70:
661–673.
48. Goritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, et al. (2011) A
Pericyte Origin of Spinal Cord Scar Tissue. Science 333: 238–242.
49. Hamilton TG, Klinghoffer RA, Corrin PD, Soriano P (2003) Evolutionary
Divergence of Platelet-Derived Growth Factor Alpha Receptor Signaling
Mechanisms. Molecular and Cellular Biology 23: 4013–4025.
50. Bondjers C, He L, Takemoto M, Norlin J, Asker N, et al. (2006) Microarray
analysis of blood microvessels from PDGF-B and PDGF-Rbeta mutant mice
identifies novel markers for brain pericytes. FASEB J 20: 1703–1705.
51. Montiel-Eulefi E, Nery AA, Rodrigues LC, Sa ´nchez R, Romero F, et al. (2012)
Neural differentiation of rat aorta pericyte cells. Cytometry A 81: 65–71.
52. Wang S, Sdrulla AD, diSibio G, Bush G, Nofziger D, et al. (1998) Notch
receptor activation inhibits oligodendrocyte differentiation. Proc Natl Acad Sci
USA 21: 63–75.
53. Yamamoto S, Nagao M, Sugimori M, Kosako H, Nakatomi H, et al. (2001)
Transcription factor expression and Notch-dependent regulation of neural
progenitors in the adult rat spinal cord. J Neurosci 21: 9814–9823.
54. Grandbarbe L, Bouissac J, Rand M, Hrabe ´ de Angelis M, Artavanis-Tsakonas S,
et al. (2003) Delta-Notch signaling controls the generation of neurons/glia from
neural stem cells in a stepwise process. Development 130: 1391–1402.
55. Sellers DL, Maris DO, Horner PJ (2009) Postinjury Niches Induce Temporal
Shifts in Progenitor Fates to Direct Lesion Repair after Spinal Cord Injury.
J Neurosci 29: 6722–6733.
56. White BD, Nathe RJ, Maris DO, Nguyen NK, Goodson JM, et al. (2010) Beta-
catenin signaling increases in proliferating NG2+ progenitors and astrocytes
during post-traumatic gliogenesis in the adult brain. Stem Cells 28: 297–307.
Multipotency of Polydendrocytes after Ischemia
PLoS ONE | www.plosone.org 14 May 2012 | Volume 7 | Issue 5 | e36816